The University of Chicago Header Logo

Connection

Elaine M. Worcester to Kidney Calculi

Back to Details
This is a "connection" page, showing publications Elaine M. Worcester has written about Kidney Calculi.
Elaine M. Worcester
Connection Strength
17.501
Kidney Calculi
  1. Contrasting Response of Urine Stone Risk to Medical Treatment in Calcium Oxalate versus Calcium Phosphate Stone Formers. Kidney360. 2024 Feb 01; 5(2):228-236.
    View in: PubMed
    Score: 0.750
  2. Contribution of thick ascending limb and distal convoluted tubule to glucose-induced hypercalciuria in healthy controls. Am J Physiol Renal Physiol. 2023 12 01; 325(6):F811-F816.
    View in: PubMed
    Score: 0.735
  3. Metabolomic profiles and pathogenesis of nephrolithiasis. Curr Opin Nephrol Hypertens. 2023 09 01; 32(5):490-495.
    View in: PubMed
    Score: 0.724
  4. Water Loading and Uromodulin Secretion in Healthy Individuals and Idiopathic Calcium Stone Formers. Clin J Am Soc Nephrol. 2023 08 01; 18(8):1059-1067.
    View in: PubMed
    Score: 0.717
  5. Stone Morphology Distinguishes Two Pathways of Idiopathic Calcium Oxalate Stone Pathogenesis. J Endourol. 2022 05; 36(5):694-702.
    View in: PubMed
    Score: 0.665
  6. Sex Differences of Kidney Stone Urine Risk Factors after Roux-en-Y Gastric Bypass. Am J Nephrol. 2021; 52(2):173-176.
    View in: PubMed
    Score: 0.616
  7. Risk Factors for Kidney Stone Formation following Bariatric Surgery. Kidney360. 2020 12; 1(12):1456-1461.
    View in: PubMed
    Score: 0.606
  8. Evidence for disordered acid-base handling in calcium stone-forming patients. Am J Physiol Renal Physiol. 2020 02 01; 318(2):F363-F374.
    View in: PubMed
    Score: 0.563
  9. Randall's plaque in stone formers originates in ascending thin limbs. Am J Physiol Renal Physiol. 2018 11 01; 315(5):F1236-F1242.
    View in: PubMed
    Score: 0.513
  10. Evidence for a role of PDZ domain-containing proteins to mediate hypophosphatemia in calcium stone formers. Nephrol Dial Transplant. 2018 05 01; 33(5):759-770.
    View in: PubMed
    Score: 0.504
  11. Sex differences in proximal and distal nephron function contribute to the mechanism of idiopathic hypercalcuria in calcium stone formers. Am J Physiol Regul Integr Comp Physiol. 2015 Jul 01; 309(1):R85-92.
    View in: PubMed
    Score: 0.410
  12. A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I. Am J Physiol Renal Physiol. 2013 Dec 01; 305(11):F1574-84.
    View in: PubMed
    Score: 0.367
  13. Kidney stones: an update on current pharmacological management and future directions. Expert Opin Pharmacother. 2013 Mar; 14(4):435-47.
    View in: PubMed
    Score: 0.352
  14. Pathophysiology-based treatment of idiopathic calcium kidney stones. Clin J Am Soc Nephrol. 2011 Aug; 6(8):2083-92.
    View in: PubMed
    Score: 0.316
  15. Clinical practice. Calcium kidney stones. N Engl J Med. 2010 Sep 02; 363(10):954-63.
    View in: PubMed
    Score: 0.296
  16. Evidence for altered renal tubule function in idiopathic calcium stone formers. Urol Res. 2010 Aug; 38(4):263-9.
    View in: PubMed
    Score: 0.294
  17. Plaque and deposits in nine human stone diseases. Urol Res. 2010 Aug; 38(4):239-47.
    View in: PubMed
    Score: 0.294
  18. Intra-tubular deposits, urine and stone composition are divergent in patients with ileostomy. Kidney Int. 2009 Nov; 76(10):1081-8.
    View in: PubMed
    Score: 0.276
  19. Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism. BJU Int. 2009 Mar; 103(5):670-8.
    View in: PubMed
    Score: 0.259
  20. Evidence for increased postprandial distal nephron calcium delivery in hypercalciuric stone-forming patients. Am J Physiol Renal Physiol. 2008 Nov; 295(5):F1286-94.
    View in: PubMed
    Score: 0.257
  21. Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time. Nephrol Dial Transplant. 2009 Jan; 24(1):130-6.
    View in: PubMed
    Score: 0.256
  22. Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones. Kidney Int. 2008 Jul; 74(2):223-9.
    View in: PubMed
    Score: 0.252
  23. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. Anat Rec (Hoboken). 2008 Mar; 291(3):325-34.
    View in: PubMed
    Score: 0.249
  24. Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone. Semin Nephrol. 2008 Mar; 28(2):111-9.
    View in: PubMed
    Score: 0.249
  25. Mechanism of formation of human calcium oxalate renal stones on Randall's plaque. Anat Rec (Hoboken). 2007 Oct; 290(10):1315-23.
    View in: PubMed
    Score: 0.242
  26. Renal histopathology of stone-forming patients with distal renal tubular acidosis. Kidney Int. 2007 Apr; 71(8):795-801.
    View in: PubMed
    Score: 0.231
  27. Pathophysiological correlates of two unique renal tubule lesions in rats with intestinal resection. Am J Physiol Renal Physiol. 2006 Nov; 291(5):F1061-9.
    View in: PubMed
    Score: 0.227
  28. Renal function in patients with nephrolithiasis. J Urol. 2006 Aug; 176(2):600-3; discussion 603.
    View in: PubMed
    Score: 0.223
  29. Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int. 2006 Jun; 69(12):2227-35.
    View in: PubMed
    Score: 0.220
  30. Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int. 2006 Apr; 69(8):1313-8.
    View in: PubMed
    Score: 0.218
  31. A new animal model of hyperoxaluria and nephrolithiasis in rats with small bowel resection. Urol Res. 2005 Nov; 33(5):380-2.
    View in: PubMed
    Score: 0.212
  32. Kidney stone disease. J Clin Invest. 2005 Oct; 115(10):2598-608.
    View in: PubMed
    Score: 0.211
  33. Insights on the pathology of kidney stone formation. Urol Res. 2005 Nov; 33(5):383-9.
    View in: PubMed
    Score: 0.208
  34. Nephrolithiasis and increased blood pressure among females with high body mass index. Am J Kidney Dis. 2005 Aug; 46(2):263-9.
    View in: PubMed
    Score: 0.208
  35. Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization. Kidney Int. 2005 Jul; 68(1):145-54.
    View in: PubMed
    Score: 0.207
  36. Causes and consequences of kidney loss in patients with nephrolithiasis. Kidney Int. 2003 Dec; 64(6):2204-13.
    View in: PubMed
    Score: 0.186
  37. A spatially anchored transcriptomic atlas of the human kidney papilla identifies significant immune injury in patients with stone disease. Nat Commun. 2023 07 19; 14(1):4140.
    View in: PubMed
    Score: 0.181
  38. End Point Considerations for Clinical Trials in Enteric Hyperoxaluria. Clin J Am Soc Nephrol. 2023 12 01; 18(12):1637-1644.
    View in: PubMed
    Score: 0.180
  39. Stones from bowel disease. Endocrinol Metab Clin North Am. 2002 Dec; 31(4):979-99.
    View in: PubMed
    Score: 0.173
  40. Clinical Effectiveness of Calcium Oxalate Stone Treatments. Am J Nephrol. 2022; 53(10):761-766.
    View in: PubMed
    Score: 0.173
  41. What treatments reduce kidney stone risk in patients with bowel disease? Urolithiasis. 2022 Oct; 50(5):557-565.
    View in: PubMed
    Score: 0.170
  42. Collagen fibrils and cell nuclei are entrapped within Randall's plaques but not in CaOx matrix overgrowth: A microscopic inquiry into Randall's plaque stone pathogenesis. Anat Rec (Hoboken). 2022 07; 305(7):1701-1711.
    View in: PubMed
    Score: 0.162
  43. Evidence for abnormal linkage between urine oxalate and citrate excretion in human kidney stone formers. Physiol Rep. 2021 07; 9(13):e14943.
    View in: PubMed
    Score: 0.157
  44. Demineralization and sectioning of human kidney stones: A molecular investigation revealing the spatial heterogeneity of the stone matrix. Physiol Rep. 2021 01; 9(1):e14658.
    View in: PubMed
    Score: 0.152
  45. Multimodal imaging reveals a unique autofluorescence signature of Randall's plaque. Urolithiasis. 2021 Apr; 49(2):123-135.
    View in: PubMed
    Score: 0.149
  46. Racial Differences in Risk Factors for Kidney Stone Formation. Clin J Am Soc Nephrol. 2020 08 07; 15(8):1166-1173.
    View in: PubMed
    Score: 0.146
  47. Discrepancy Between Stone and Tissue Mineral Type in Patients with Idiopathic Uric Acid Stones. J Endourol. 2020 03; 34(3):385-393.
    View in: PubMed
    Score: 0.142
  48. In Vivo Renal Tubule pH in Stone-Forming Human Kidneys. J Endourol. 2020 02; 34(2):203-208.
    View in: PubMed
    Score: 0.142
  49. Mechanisms for falling urine pH with age in stone formers. Am J Physiol Renal Physiol. 2019 07 01; 317(7):F65-F72.
    View in: PubMed
    Score: 0.135
  50. Association Between Randall's Plaque Stone Anchors and Renal Papillary Pits. J Endourol. 2019 04; 33(4):337-342.
    View in: PubMed
    Score: 0.134
  51. Papillary Ductal Plugging is a Mechanism for Early Stone Retention in Brushite Stone Disease. J Urol. 2018 01; 199(1):186-192.
    View in: PubMed
    Score: 0.120
  52. Endoscopic Evidence That Randall's Plaque is Associated with Surface Erosion of the Renal Papilla. J Endourol. 2017 01; 31(1):85-90.
    View in: PubMed
    Score: 0.115
  53. What can the microstructure of stones tell us? Urolithiasis. 2017 Feb; 45(1):19-25.
    View in: PubMed
    Score: 0.114
  54. Idiopathic hypercalciuria and formation of calcium renal stones. Nat Rev Nephrol. 2016 09; 12(9):519-33.
    View in: PubMed
    Score: 0.111
  55. Formation of hydrated calcium oxalates in the presence of poly-L-aspartic acid. Scanning Microsc. 1996; 10(2):415-23; 423-4.
    View in: PubMed
    Score: 0.107
  56. A Proposed Grading System to Standardize the Description of Renal Papillary Appearance at the Time of Endoscopy in Patients with Nephrolithiasis. J Endourol. 2016 Jan; 30(1):122-7.
    View in: PubMed
    Score: 0.106
  57. Nephrocalcinosis in Calcium Stone Formers Who Do Not have Systemic Disease. J Urol. 2015 Nov; 194(5):1308-12.
    View in: PubMed
    Score: 0.103
  58. Biopsy proven medullary sponge kidney: clinical findings, histopathology, and role of osteogenesis in stone and plaque formation. Anat Rec (Hoboken). 2015 May; 298(5):865-77.
    View in: PubMed
    Score: 0.101
  59. Mechanisms of human kidney stone formation. Urolithiasis. 2015 Jan; 43 Suppl 1:19-32.
    View in: PubMed
    Score: 0.097
  60. Micro-CT imaging of Randall's plaques. Urolithiasis. 2015 Jan; 43 Suppl 1:13-7.
    View in: PubMed
    Score: 0.097
  61. Contrasting histopathology and crystal deposits in kidneys of idiopathic stone formers who produce hydroxy apatite, brushite, or calcium oxalate stones. Anat Rec (Hoboken). 2014 Apr; 297(4):731-48.
    View in: PubMed
    Score: 0.094
  62. Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones. Am J Physiol Renal Physiol. 2011 Feb; 300(2):F311-8.
    View in: PubMed
    Score: 0.075
  63. Comparison of the pathology of interstitial plaque in human ICSF stone patients to NHERF-1 and THP-null mice. Urol Res. 2010 Dec; 38(6):439-52.
    View in: PubMed
    Score: 0.075
  64. Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease. Kidney Int. 2010 Aug; 78(3):310-7.
    View in: PubMed
    Score: 0.072
  65. Three pathways for human kidney stone formation. Urol Res. 2010 Jun; 38(3):147-60.
    View in: PubMed
    Score: 0.072
  66. In idiopathic calcium oxalate stone-formers, unattached stones show evidence of having originated as attached stones on Randall's plaque. BJU Int. 2010 Jan; 105(2):242-5.
    View in: PubMed
    Score: 0.068
  67. Trends in kidney donation among kidney stone formers: a survey of US transplant centers. Am J Nephrol. 2009; 30(1):12-8.
    View in: PubMed
    Score: 0.066
  68. Crystal adsorption and growth slowing by nephrocalcin, albumin, and Tamm-Horsfall protein. Am J Physiol. 1988 Dec; 255(6 Pt 2):F1197-205.
    View in: PubMed
    Score: 0.066
  69. A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall's plaque. BJU Int. 2009 Apr; 103(7):966-71.
    View in: PubMed
    Score: 0.065
  70. New insights into the pathogenesis of idiopathic hypercalciuria. Semin Nephrol. 2008 Mar; 28(2):120-32.
    View in: PubMed
    Score: 0.062
  71. Endoscopic evidence of calculus attachment to Randall's plaque. J Urol. 2006 May; 175(5):1720-4; discussion 1724.
    View in: PubMed
    Score: 0.055
  72. Evidence against a contribution of conventional urine risk factors to de novo ESRD renal stones. Nephrol Dial Transplant. 2006 Mar; 21(3):701-6.
    View in: PubMed
    Score: 0.053
  73. Nephrolithiasis and nephrocalcinosis in rats with small bowel resection. Urol Res. 2005 May; 33(2):105-15.
    View in: PubMed
    Score: 0.051
  74. Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int. 2005 Feb; 67(2):576-91.
    View in: PubMed
    Score: 0.050
  75. Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int. 2005 Feb; 67(2):685-90.
    View in: PubMed
    Score: 0.050
  76. Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. Kidney Int. 2004 Aug; 66(2):777-85.
    View in: PubMed
    Score: 0.049
  77. Relative contributions of urine sulfate, titratable urine anion, and GI anion to net acid load and effects of age. Physiol Rep. 2021 05; 9(10):e14870.
    View in: PubMed
    Score: 0.039
  78. Role of anionic proteins in kidney stone formation: interaction between model anionic polypeptides and calcium oxalate crystals. J Urol. 2000 Apr; 163(4):1343-8.
    View in: PubMed
    Score: 0.036
  79. Hypercalciuria and stones. Am J Kidney Dis. 1991 Apr; 17(4):386-91.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.